Patient engagement through advisory boards, surveys, and listening sessions can help address industry challenges like trial ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

The globalization of clinical research provides great opportunities for significantly improving the efficiency of the drug development process. For pharmaceutical companies, the benefits of ...

Drug development is a costly, time-intensive and high-risk endeavour, with only two to three approvals for novel therapeutics in new drug classes per year eventually making it to market.

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

Leveraging Commercial Data Infrastructure in Clinical Drug Development is the greatest connectivity we can have in the ...

CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...

cutting years off the drug development process. The team believe their approach could also save millions of pounds by highlighting which projects or clinical trials are likely to fail. The work ...

With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are ...

Absci is preparing to send its first internally developed drug to clinical trials. The Vancouver-based ... to the market faster than the traditional process. The company reported losing $103.1 ...

The new technology, which has been developed by a team at The Institute of Cancer Research, London, will allow researchers to quickly assess the ability of new drugs to reach their intended target, ...

Good Manufacturing Process ... the clinical grade drug substances will be formulated into the final drug product, ready for stability testing, and use in the clinical trials pending required ...